Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer ResectionJohn P. Neoptolemos, for the European Study Group for Pancreatic Cancer, Robert Padbury et al.|JAMA|2010Cited by 1.4k
Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary AdenocarcinomaJohn P. Neoptolemos, Malcolm J. Moore, Trevor F. Cox et al.|JAMA|2012Cited by 590
Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 TrialWilliam Greenhalf, Markus W. Büchler, Paula Ghaneh et al.|JNCI Journal of the National Cancer Institute|2013Cited by 333
Ampullary cancer ESPAC-3 (v2) trial: A multicenter, international, open-label, randomized controlled phase III trial of adjuvant chemotherapy versus observation in patients with adenocarcinoma of the ampulla of vater.John P. Neoptolemos, Malcolm J. Moore, Trevor F. Cox et al.|Journal of Clinical Oncology|2011Cited by 24